$PFE news
The latest PFE stock news: headlines, filings, AI summaries and sentiment for $PFE, updated around the clock.
- Ascendis Pharma Reports Q3 Revenue Growth of 90.7% Year-over-Year
- Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Development
- Protalix BioTherapeutics Reports Q3 2026 Revenue Growth Driven by Elfabrio Sales
- Medicus Pharma Reports Q3 2026 Financial Results and Strategic Shift Toward Precision Oncology
- Weekly Healthcare Market Update: Focus on Moderna, Pfizer, and CVS Health
- Healthcare Sector Reports Strong Earnings Performance with 96% EPS Beat Rate
- Democratic Lawmakers Plan Investigation Into Trump Administration Drug Pricing Deals
- Celcuity Reports Q3 2026 Financial Results and Revtopik Commercial Launch Progress
- OPKO Health Reports Q3 2026 Revenue Growth and Completes BioReference Asset Sale
- Pfizer Reports Q3 2026 Earnings Beat and Raises Full-Year Guidance
- Pfizer Raises 2026 Revenue Guidance Amid Strong Growth in Acquired Products
- United Therapeutics Acquires Pfizer Royalty Interest in Experimental Lung Therapy Ralinepag
- Pfizer Raises 2026 Revenue and EPS Guidance Amid Strong Product Growth
- PFIZER INC - 8-K Filing
- Pfizer Reports Q3 2026 Results with Increased Full-Year Guidance Amid Non-COVID Growth
- Market Analysis: Midterm Election Uncertainty and Tech Earnings Impact
- Midday Market Update: Mixed Earnings Results Drive Volatility Across Tech and Financial Sectors
- Market Update: Mixed Trading Amid Election Anticipation and Pfizer Outlook Revision
- Pfizer Raises 2026 Financial Outlook and Appoints New CFO
- Pfizer Reports Flat Third-Quarter Revenue and Raises Full-Year Guidance
- Pfizer Raises Annual Profit and Revenue Forecasts Driven by Eliquis Demand
- Pfizer Exceeds Q3 Earnings Expectations and Raises Full-Year Guidance
- PFIZER INC - 10-Q Filing
- PFIZER INC - 8-K Filing
- Premarket Stock Movements: Pfizer, Apple, Palantir, and Zebra Technologies Report Q3 Results
- Pfizer Reports Strong Revenue and EPS Beat Driven by Primary Care Growth
- Protalix BioTherapeutics Schedules Third Quarter 2026 Financial Results and Business Update
- Pfizer Raises Full-Year Guidance and Appoints Cecile Guegan as CFO
- Market Outlook: Apple Earnings, Tech Sector Declines, and Midterm Election Impact on AI Infrastructure
- S&P 500 Futures Flat Amid Apple Earnings Disappointment and Midterm Election Uncertainty
- Key Corporate Earnings Scheduled Before Market Open on Tuesday
- CopperWood Senior Living to Begin Adaptive Reuse of Historic Pfizer Campus in New Jersey
- Pfizer Announces Successful Late-Stage Trial for Multiple Myeloma Drug Elrexfio
- FDA Approves Pfizer's Talzenna and Xtandi Combination for Metastatic Hormone-Sensitive Prostate Cancer
- Celcuity Reports Improved Progression-Free Survival with Revtorpyk in Phase 3 Breast Cancer Trial
- European Commission Approves Merck and Pfizer/Astellas Combination Therapy for Bladder Cancer
- Cboe Expands Trading Hours with Extended Sessions for Select Single Stock and ETF Options
- Pfizer Offers 6% Dividend Yield and Growth Potential Beyond Its COVID-19 Portfolio
- Pfizer Announces Closure of Penicillin Unit in Sicily with Job Cuts
- Pfizer's Tukysa Approved by FDA for Front-Line Breast Cancer Treatment
- Pfizer Announces $0.43 Quarterly Dividend
- Stocks Making Significant Moves Midday: Microsoft, SpaceX, Vaxcyte, Banco Bradesco, DraftKings Among Others
- Pfizer, Sanofi, and Novartis Highlight Key Healthcare News of the Week
- AbbVie Included in New 340B Rebate Pilot Program
- Pfizer Reports Positive Phase 3 Results for Vitiligo Treatment Litfulo
- Florida AG Files Lawsuit Against Pfizer Over Alleged Misconduct Regarding Vaccine Risks
- Pfizer's Eczema Drug Tilrekimig Shows Strong Results in Mid-Stage Trial
- Pfizer Shares Rise for Seven Consecutive Sessions
- Cybersecurity Startup Island Secures $400M at $6.4B Valuation Amid Rising AI Security Concerns
- Biggest Stock Movers on Thursday Include P, VKTX, and MGM